Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

º¸»ó¿©°úÆÇÀ» ÀÌ¿ëÇÑ ºñÀΰ­¾ÏÀÇ Àü¹æÀ§ °­µµº¯Á¶ ¹æ»ç¼±Ä¡·á°èȹ Dose Planning of Forward Intensity Modulated Radiation Therapy for Nasopharyngeal Cancer using Compensating Filters

´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 2001³â 19±Ç 1È£ p.53 ~ 65
Ãß¼º½Ç, ÀÌ»ó¿í, ¼­Ã¢¿Á, ±è±Í¾ð,
¼Ò¼Ó »ó¼¼Á¤º¸
Ãß¼º½Ç (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±Á¾¾çÇб³½Ç

ÀÌ»ó¿í (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±Á¾¾çÇб³½Ç
¼­Ã¢¿Á (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±Á¾¾çÇб³½Ç
±è±Í¾ð (  ) 
¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ ¹æ»ç¼±Á¾¾çÇб³½Ç

Abstract

¸ñÀû: ºñÀΰ­¾Ï ȯÀÚÀÇ ±¹¼ÒÁ¦¾îÀ²À» Çâ»ó½ÃÅ°±â À§ÇÑ ¸ñÀûÀ¸·Î º¸»ó ¿©°úÆÇÀ» ÀÌ¿ëÇÑ Àü¹æÀ§ °­µµº¯Á¶ ¹æ»ç¼±Ä¡·á¹æ¹ý(intensity modulated radiation therapy: IMRT)À» °èȹÇÏ°í ±âÁ¸ 3Â÷¿ø ÀÔüÁ¶ÇüÄ¡·á¹æ¹ý°ú ºñ±³ÇÏ¿© ÃÖÀûÀÇ ¹æ»ç¼±Ä¡·á¹æ¹ýÀ» ¸ð»öÇÏ°íÀÚ
ÇÑ´Ù.
´ë»ó ¹× ¹æ¹ý: 3-Â÷¿ø ÀÔüÁ¶ÇüÄ¡·á°èȹÀ¸·Î Ä¡·á¹Þ¾Ò´ø ºñ°­¾ÏȯÀÚ(T4N0M0) 1¿¹¸¦ ¼±ÅÃ
ÇÏ¿© Ä¡·á¸éÀÇ ±¼°î°ú »À, °øµ¿ µî ºÒ±ÕÁú Á¶Á÷À¸·Î ÀÎÇÏ¿© ¹ß»ýµÇ´Â Ç¥ÀûüÀûÀÇ ¼±·®ºÐÆ÷
¸¦ ±ÕÀÏÇÏ°Ô ¸¸µé°í ÁÖº¯ Á¤»óÀå±âÀÇ ¼Õ»óÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇÑ ÀÏÂ÷ ÀԻ缱·®ÀÇ °­µµ Á¶ÀýÀ»
º¸»ó¿©°úÆÇÀ¸·Î ½ÃÇàÇÏ¿´´Ù. ȯÀÚ´Â ¿­º¯¼º plastic mask·Î °íÁ¤½ÃŲ ÈÄ Ä¡·áÁ¶ÁØ¿ë CT
Scan (PQ5000)À» ÀÌ¿ëÇÏ¿© 3 mm °£°ÝÀ¸·Î scan ÇÏ°í °¡»óÁ¶ÁØÀåÄ¡(virtual simulator)¿Í 3
Â÷¿ø ¹æ»ç¼±Ä¡·á°èȹ ÄÄÇ»ÅÍ(ADAC-pinnacle3)¸¦ ÀÌ¿ëÇÏ¿© º¸»ó¿©°úÆÇÀ» Á¦
ÀÛÇÏ¿³´Ù. °¢ Á¶»ç¸éÀ» ¼¼ºÐÇÑ ¼ÒÁ¶»ç¼±(beamlet)ÀÇ °­µµ °¡ÁßÄ¡(weighting)¸¦ °è»êÇÏ°í °¡
ÁßÄ¡¿¡ µû¸¥ ¼±·® °¨¾àÀ» º¸»ó¿©°úÆÇÀÇ µÎ²²·Î ȯ»êÇÏ¿© ÆǺ°ÀÌ ½±µµ·Ï µµÇ¥È­ÇÏ¿´´Ù. ¹æ»ç
¼± Ä¡·á¼º°úÀÇ ±âÁØÀº Á¤·®ÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ´Â ¼±·®Ã¼ÀûÇ¥(dose volume
histogram:DVH)¿Í Á¾¾ç¾ïÁ¦È®À²(tumor control probability : TCP) ¹× Á¤»óÁ¶Á÷ ¼Õ»óÈ®À²
(normal tissue complication probability : NTCP)ÀÇ ¼öÇÐÀû °ü°è½ÄÀ» ÀÌ¿ëÇÏ¿© Ä¡·áÈ¿°ú¸¦
Æò°¡ÇÏ¿´´Ù.
°á°ú : Àü¹æÀ§ IMRT¿¡¼­ °èȹ¿ëÇ¥ÀûüÀû(planning targer volume : PTV)³»ÀÇ ÃÖ¼Ò¼±·®°ú
ÃÖ´ë¼±·®ÀÇ Â÷ÀÌ°¡ ÀÔüÁ¶ÇüÄ¡·á°èȹº¸´Ù ¾à°£ Áõ°¡ÇÏ¿´À¸¸ç Æò±Õ¼±·®Àº °­µµÁ¶ÀýÄ¡·á°èȹ
¿¡¼­ ¾à 10% ´õ ³ô¾Ò°í Àüü ¹æ»ç¼±·®ÀÇ 95%°¡ Æ÷ÇԵǴ üÀû(V95)Àº ºñ±³Àû ¾çÂÊ ¼³°è¹æ
¹ý¿¡¼­ ºñ½ÁÇÑ ¾ç»óÀ» º¸ÀÌ°í ÀÖ¾ú´Ù. ÁÖÀ§ °Ç°­Àå±âµéÀÇ DVH¿¡¼­ ¹æ»ç¼±¿¡ ¹Î°¨ÇÑ Àå±â
ÀÎ ½Ã½Å°æ, ÃøµÎ¿±, ÀÌÇϼ±, ³ú°£, ô¼ö, ÃøµÎÇϾǰñ°üÀý µîÀº °­µµÁ¶ÀýÄ¡·á°èȹ¿¡¼­ ¸¹ÀÌ
º¸È£µÇ¾ú´Ù. PTVÀÇ Á¾¾çÁ¦¾îÈ®À²Àº ÀÔüÁ¶ÇüÄ¡·á°èȹ°ú °­µµº¯Á¶Ä¡·á°èȹ¿¡¼­ ¸ðµÎ ºñ±³Àû
±ÕÀÏÇÏ¿´À¸¸ç °èȹ¼±·®ÀÌ 50 Gy¿¡¼­ 80 Gy·Î Áõ°¡ÇÔ¿¡ µû¶ó TCP°¡ 0.45¿¡¼­ 0.56À¸·Î ¿Ï
¸¸ÇÏ°Ô Áõ°¡ÇÏ¿´´Ù. ô¼ö, ÃøµÎÇϾǰñ °üÀý, ³ú°£, ÃøµÎ¿±, ÀÌÇϼ±, ½Ã½Å°æ±³Â÷, ½Ã½Å°æ µî Á¤
»óÀå±âÀÇ ¼Õ»óÈ®À²Àº ÀÔüÁ¶ÇüÄ¡·á°èȹº¸´Ù °­µµÁ¶ÀýÄ¡·á°èȹ¿¡¼­ ¿ùµîÈ÷ °¨¼ÒµÇ¾úÀ¸¸ç Ư
È÷ ³ú°£ (brain stem)ÀÇ NTCP´Â ÀÔüÁ¶ÇüÄ¡·á°èȹ¿¡¼­ º¸´Ù °­µµÁ¶ÀýÄ¡·á°èȹ¿¡¼­ ÈξÀ
ÀûÀº °ª(0.3¿¡¼­ 0.15)À¸·Î °¨¼ÒµÇ¾ú´Ù. °èȹ¼±·®ÀÇ Áõ°¡¿¡ µû¸¥ TCP¿Í NTCT¸¦ ÀÔüÁ¶Çü
Ä¡·á°èȹ°ú °­µµÁ¶ÀýÄ¡·á°èȹ¿¡¼­ TCP´Â °øÈ÷ ¿Ï¸¸ÇÑ Áõ°¡¸¦ º¸¿´À¸³ª NTCT°ªÀº ¼±·®Áõ
°¡¿¡ ºñ·ÊÀûÀ¸·Î Áõ°¡ÇÏ¿´°í ÀÔüÁ¶ÇüÄ¡·á°èȹÀÌ °­µµÁ¶ÀýÄ¡·á°èȹº¸´Ù ¿ùµîÈ÷ Áõ°¡ÇÏ¿´´Ù.
°á·Ð: º¸»ó¿©°úÆÇÀ» ÀÌ¿ëÇÑ Àü¹æÀ§ °­µµº¯Á¶ ¹æ»ç¼±Ä¡·á¿¡¼­ PTV³»ÀÇ ¼±·® ±ÕÀϵµÀÇ °³¼±
Àº ¾ø¾úÁö¸¸ ³ú°£, ô¼ö°­ µî Á¤»óÀå±âÀÇ ÇÇÆøÀ» ÁÙÀÏ ¼ö ÀÖ¾ú´Ù. ƯÈ÷ ÀÎüǥ¸éÀÇ ±¼°îÀÌ
½ÉÇϰųª »À, µ¿°ø µîÀ¸·Î Á¾¾ç¿¡ µµ´ÞÇÏ´Â ¹æ»ç¼±·®ºÐÆ÷°¡ ±ÕÀÏÇÏÁö ¾ÊÀ» °æ¿ì ¸Å¿ì À¯¸®
ÇÑ Ä¡·á¹æ¹ýÀÌ¿´´Ù. ¹æ»ç¼±Ä¡·á¼ºÀûÀ» Æò°¡ÇÔ¿¡ ÀÖ¾î DVH¿Í TCP, NTCP µî ¼öÇÐÀû ôµµ
¸¦ ÀÌ¿ëÇÔÀ¸·Î¼­ Ä¡·á¼º°úÀÇ ¿¹Ãø, Á¾¾ç¼±·®ÀÇ Áõ°¡(dose escalation), ¹æ»ç¼±¼ö¼úÀÇ ÁöÇ¥ ¹×
¹æ»ç¼±Ä¡·áÀÇ ÁúÀû »óȲÀ» Á¤·®Àû ¼öÄ¡·Î Æò°¡ÇÒ ¼ö ÀÖ¾î ¹æ»ç¼±Ä¡·á¼º°ú Çâ»ó¿¡ ±â¿©ÇÒ ¼ö
ÀÖ´Ù°í »ý°¢µÈ´Ù.

Purpose: To improve the local control of patients with nasopharyngeal cancer, we have implemented 3-D conformal radiotherapy and forward intensity modulated radiation therapy (IMRT) to used of compensating filters. Three dimension conformal
radiotherapy
with intensity modulation is a new modality for cancer treatments. We designed 3-D treatment planning with 3-D RTP (radiation treatment planning system) and evaluation dose distribution with tumor control probability (TCP) and normal tissue
complication
probability (NTCP).
Material and Methods: We have developed a treatment plan consisting four intensity
modulated photon fields that are delivered through the compensating filters and block
transmission for critical organs. We get a full size CT imaging including head and neck
as 3 mm slices, and delineating PTV (planning targer volume) and surrounding critical
organs, and reconstructed 3D imaging on the computer windows. In the planning stage,
the planner specifies the number of beams and their directions including non-coplanar,
and the prescribed doses for the target volume and the permissible dose of normal
organs and the overlap regions. We designed compensating filter according to tissue
deficit and PTV volume shape also dose weighting for each field to obtain adequate
dose distribution, and shielding blocks weighting for transmission. Therapeutic gains
were evaluated by numerical equation of tumor control probability and normal tissue
complication probability. The TCP and NTCP by DVH (dose volume histogram) were
compared with the 3-D conformal radiotherapy and forward intensity modulated
conformal radiotherapy by compensator and blocks weighting. Optimization for the
weight distribution was performed iteration with initial guess weight or the even weight
distribution. The TCP and NTCP by DVH were compared with the 3-D conformal
radiotherapy and intensity modulated conformal radiotherapy by compensator and blocks
weighting.
Results: Using a four field IMRT plan, we have customized dose distribution to conform
and deliver sufficient dose to the PTV. In addition, in the overlap regions between the
PTV and the normal organs (spinal cord, salivary grand, pituitary, optic nerves), the
dose is kept within the tolerance of the respective organs. We evaluated to obtain
sufficient TCP value and acceptable NTCP using compensating filter. Quality assurance
checks show acceptable agreement between the planned and the implemented
MLC(multi-leaf collimator).
Conclusion: IMRT provides a powerful and efficient solution for complex planning
problems where the surrounding normal tissues place severe constraints on the
prescription dose. The intensity modulated fields can be efficaciously and accurately
delivered using compensating filters.

Å°¿öµå

Àü¹æÀ§ °­µµº¯Á¶ ¹æ»ç¼±Ä¡·á; ¹æ»ç¼± ÀÔü Á¶ÇüÄ¡·á; Á¾¾ç¾ïÁ¦È®À²; Á¤»óÁ¶Á÷¼Õ»óÈ®À²; ¼±·®Ã¼ÀûÇ¥; Forward intensity modulated radiation therapy; 3D conformal radiotherapy; Tumor control probability; Normal tissue complication probability; Dose volume histogra

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS